Alston & Bird LLP has strengthened its team by hiring former FDA Deputy Counsel and ex-DLA Piper attorney, marking a significant shift for the firm’s regulatory practice aimed at enhancing its expertise in FDA compliance and medical product regulatory disputes. This strategic addition is expected to bolster the firm’s ability to advise companies facing complex regulatory challenges in the pharmaceutical and medical device sectors.
The attorney, whose credentials include extensive experience at the U.S. Food and Drug Administration, brings a wealth of knowledge in navigating the intricate landscape of FDA regulations. This move is seen as part of a broader trend where law firms are increasingly seeking seasoned professionals with inside knowledge of regulatory agencies to better serve their clients in highly regulated industries. Alston & Bird’s development aligns with this trend as legal operations require adept handling of compliance matters in an era of heightened regulatory scrutiny.
According to Law360, this new hire’s role will focus on guiding companies through the complexities of FDA processes and assisting in litigation matters related to medical products. Such expertise is invaluable, especially for corporations that must adeptly manage regulatory risks while navigating the introduction of new products into the market.
Alston & Bird’s latest recruitment exemplifies how the firm aims to anticipate client needs by integrating professionals with robust regulatory backgrounds. By tapping into the experience of legal professionals who have firsthand knowledge of agency operations, law firms can offer specialized insights that support their clients’ strategic goals, particularly amidst continuously evolving legal landscapes.